JP7074753B2 - リスク因子モニタリング - Google Patents

リスク因子モニタリング Download PDF

Info

Publication number
JP7074753B2
JP7074753B2 JP2019530087A JP2019530087A JP7074753B2 JP 7074753 B2 JP7074753 B2 JP 7074753B2 JP 2019530087 A JP2019530087 A JP 2019530087A JP 2019530087 A JP2019530087 A JP 2019530087A JP 7074753 B2 JP7074753 B2 JP 7074753B2
Authority
JP
Japan
Prior art keywords
sample
input signal
pulse
output signal
risk factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019530087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019537026A (ja
JP2019537026A5 (enExample
Inventor
ウー，ホァン－ピン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ascensia Diabetes Care Holdings AG
Original Assignee
Ascensia Diabetes Care Holdings AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings AG filed Critical Ascensia Diabetes Care Holdings AG
Publication of JP2019537026A publication Critical patent/JP2019537026A/ja
Publication of JP2019537026A5 publication Critical patent/JP2019537026A5/ja
Application granted granted Critical
Publication of JP7074753B2 publication Critical patent/JP7074753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Electrochemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2019530087A 2016-12-05 2017-12-01 リスク因子モニタリング Active JP7074753B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662430232P 2016-12-05 2016-12-05
US62/430,232 2016-12-05
PCT/IB2017/057584 WO2018104835A1 (en) 2016-12-05 2017-12-01 Risk factor monitoring

Publications (3)

Publication Number Publication Date
JP2019537026A JP2019537026A (ja) 2019-12-19
JP2019537026A5 JP2019537026A5 (enExample) 2021-01-21
JP7074753B2 true JP7074753B2 (ja) 2022-05-24

Family

ID=60788637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019530087A Active JP7074753B2 (ja) 2016-12-05 2017-12-01 リスク因子モニタリング

Country Status (6)

Country Link
US (1) US11353417B2 (enExample)
EP (1) EP3548881A1 (enExample)
JP (1) JP7074753B2 (enExample)
CN (1) CN110249219B (enExample)
CA (1) CA3045090A1 (enExample)
WO (1) WO2018104835A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021092524A1 (en) * 2019-11-07 2021-05-14 Smylio Inc. Saliva collection and testing system
EP4192347A1 (en) 2020-08-04 2023-06-14 Ascensia Diabetes Care Holdings AG Continuous analyte monitoring sensor calibration and measurements by a connection function
CN114242253B (zh) * 2022-02-21 2022-05-17 深圳大学 一种用于糖尿病酮症酸中毒预警的健康管理方法及系统
CN118111933B (zh) * 2023-10-31 2025-04-04 南方医科大学南方医院 基于尿酸单钠晶体生长速率评估痛风发作风险的设备
CN120232970A (zh) * 2023-12-28 2025-07-01 江苏鱼跃凯立特生物科技有限公司 一种血糖浓度计算方法及传感器
CN120232968A (zh) * 2023-12-28 2025-07-01 江苏鱼跃凯立特生物科技有限公司 一种测试生物样品中分析物的方法、传感器及系统

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004028887A (ja) 2002-06-27 2004-01-29 Yamaguchi Technology Licensing Organization Ltd 分子鋳型膜を利用したコレステロールセンサの開発およびそれを用いる非侵襲的なコレステロール計測法および機器
JP2010540934A (ja) 2007-09-24 2010-12-24 バイエル・ヘルスケア・エルエルシー 多領域／多電位試験センサ、方法およびシステム
JP2012247338A (ja) 2011-05-30 2012-12-13 Gunze Ltd 計測表示装置
JP2013242171A (ja) 2012-05-18 2013-12-05 Tanita Corp 濃度測定装置
JP2016065880A (ja) 2008-06-05 2016-04-28 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 検査システムのためのユーザー・インターフェース

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100432660C (zh) * 2003-05-07 2008-11-12 黄椿木 抛弃式电化学式感测试片的结构及其制作方法
US9372190B2 (en) * 2004-05-26 2016-06-21 Region Nordjylland Method of evaluation of the relative risk of developing atherosclerosis in patients
RU2453843C2 (ru) 2005-04-08 2012-06-20 Байер Хелткэр Ллк Окисляемые виды соединений в качестве внутреннего стандарта в контрольных растворах для биосенсоров
BRPI0613592A2 (pt) 2005-07-20 2011-01-18 Bayer Healthcare Llc amperometria conectada por porta
WO2007040913A1 (en) 2005-09-30 2007-04-12 Bayer Healthcare Llc Gated voltammetry
RU2465812C2 (ru) * 2006-05-08 2012-11-10 БАЙЕР ХЕЛТКЭА ЭлЭлСи Система детектирования аномального выходного сигнала для биосенсора
CN101522095B (zh) 2006-10-24 2014-04-16 拜尔健康护理有限责任公司 瞬时衰变电流分析法
CA2707300C (en) 2007-12-10 2017-09-26 Bayer Healthcare Llc Rapid-read gated amperometry
EP2223104B1 (en) 2007-12-10 2018-08-29 Ascensia Diabetes Care Holdings AG Slope-based compensation
WO2010006253A1 (en) * 2008-07-10 2010-01-14 Bayer Healthcare Llc Systems and methods including amperometric and voltammetric duty cycles
WO2010077660A1 (en) 2008-12-08 2010-07-08 Bayer Healthcare Llc Biosensor system with signal adjustment
MX2012010860A (es) 2010-03-22 2013-03-05 Bayer Healthcare Llc Compensacion residual para un biosensor.
KR102068949B1 (ko) * 2010-06-07 2020-01-21 바이엘 헬쓰케어 엘엘씨 2차 출력 신호를 포함하는 기울기-기반 보상
BR112012031375A2 (pt) 2010-06-07 2016-10-25 Bayer Healthcare Llc sistema de gerenciamento de enchimento abaixo do necessário para um biosensor
US8615366B2 (en) 2010-10-15 2013-12-24 Roche Diagnostics Operations, Inc. Handheld diabetes management device with bolus calculator
EP2758039B1 (en) * 2011-09-21 2018-01-24 Ascensia Diabetes Care Holdings AG Biosensor with error compensation
US20130116526A1 (en) * 2011-11-09 2013-05-09 Telcare, Inc. Handheld Blood Glucose Monitoring Device with Messaging Capability
US9164056B2 (en) * 2012-07-27 2015-10-20 Bayer Healthcare Llc System and method for detecting used and dried sensors
US9244036B2 (en) 2012-11-16 2016-01-26 Cilag Gmbh International System and method for determination of a concentration of at least one interfering substance and correction of glucose concentration based on the concentration of the interfering substance
EP3276355B1 (en) 2013-03-14 2020-05-06 Ascensia Diabetes Care Holdings AG Normalized calibration of analyte concentration determinations
CN105143870B (zh) * 2013-04-26 2018-03-20 松下健康医疗控股株式会社 液体试样测定装置、液体试样测定方法以及生物传感器
US9738916B2 (en) 2013-07-08 2017-08-22 Panasonic Healthcare Holdings Co., Ltd. Blood component measurement device and blood component measurement method
KR102460386B1 (ko) * 2014-04-28 2022-10-27 더 리전트 오브 더 유니버시티 오브 캘리포니아 환자 준수상태를 모니터하고 촉진하기 위한 눈에 잘 띄지 않는 무선 전자 시스템
EP3485265B1 (en) * 2016-07-12 2025-03-12 Ascensia Diabetes Care Holdings AG Method for electrochemical analysis by use of alternating output signals from two electrodes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004028887A (ja) 2002-06-27 2004-01-29 Yamaguchi Technology Licensing Organization Ltd 分子鋳型膜を利用したコレステロールセンサの開発およびそれを用いる非侵襲的なコレステロール計測法および機器
JP2010540934A (ja) 2007-09-24 2010-12-24 バイエル・ヘルスケア・エルエルシー 多領域／多電位試験センサ、方法およびシステム
JP2016065880A (ja) 2008-06-05 2016-04-28 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ 検査システムのためのユーザー・インターフェース
JP2012247338A (ja) 2011-05-30 2012-12-13 Gunze Ltd 計測表示装置
JP2013242171A (ja) 2012-05-18 2013-12-05 Tanita Corp 濃度測定装置

Also Published As

Publication number Publication date
US11353417B2 (en) 2022-06-07
CN110249219A (zh) 2019-09-17
WO2018104835A1 (en) 2018-06-14
EP3548881A1 (en) 2019-10-09
US20190346399A1 (en) 2019-11-14
WO2018104835A9 (en) 2019-05-09
JP2019537026A (ja) 2019-12-19
CA3045090A1 (en) 2018-06-14
CN110249219B (zh) 2022-08-23

Similar Documents

Publication Publication Date Title
JP7074753B2 (ja) リスク因子モニタリング
JP5856154B2 (ja) 二次出力シグナルを含む勾配に基づく補正
JP6345173B2 (ja) 改善された分析物測定技法及びシステム
JP6382820B2 (ja) ヘマトクリット非感受性グルコース濃度を判定するためのシステム及び方法
JP5782044B2 (ja) バイオセンサ用の充填量不足認識システム
US11268925B2 (en) Intertwined electrical input signals
JP2020527059A (ja) バイオセンサの生体内特性を検出する方法および電子ユニット
JP6596169B2 (ja) バイオセンサ中の干渉物質による寄与を検出する方法
JP2013528289A5 (enExample)
JP2013504053A (ja) グルコース測定方法及びシステム
JP2020517928A (ja) 分析物測定システムおよび方法
WO2012134890A1 (en) System and method for measuring an analyte in a sample and correcting for interferents
JP6309011B2 (ja) ヘマトクリット非感受性グルコース濃度を判定するためのシステム及び方法
KR20190112731A (ko) 간섭물을 갖는 생리학적 유체의 분석물 농도 결정
EP2956765A1 (en) System and method for measuring an analyte in a sample and calculating hematocrit-insensitive glucose concentrations
HK40015023A (en) Risk factor monitoring
JP2017502282A (ja) 統合試験ストリップ試料検出を含む手持ち式試験計測器定電流ドライバ
JP2022542576A (ja) 試料の分析物濃度を決定するための方法
HK1217537B (en) System and method for measuring an analyte in a sample and calculating hematocrit-insensitive glucose concentrations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201130

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201130

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20211022

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220405

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220411

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220426

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220512

R150 Certificate of patent or registration of utility model

Ref document number: 7074753

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250